Company
Hero Patch
Simplifying Chronic Care
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Anodyne is a clinical-stage biotech company simplifying chronic care for every stakeholder. We enable the transdermal delivery of multi-milligram doses and complex formulations of existing therapies and emerging large molecules.
Funding snapshot
- Total raised
- $16.8MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Series A, $12.6M2026-06-24
Funding rounds
- Series A
- $12.6M2026-06-24, Company stated
- Seed
- $4.2M2021-04-08, Company stated
Products
- Hardware
- HeroPatch
Loading relationship preview